Metabolic Characteristics of Glucose Intolerance: The Critical Role of Obesity

Abstract

Introduction: Obesity enhances insulin secretion and resistance. We investigated its importance in linking insulin metabolism to glucose intolerance.

Material and Methods: We studied 700 subjects referred by general practitioners for possible metabolic abnormalities. Plasma glucose was measured before (FPG) and after (2h-PG) OGTT, together with insulin. Insulin resistance was estimated by HOMA-IR, insulin sensitivity using ISI(gly) and ISI(Stumvoll) indexes, insulin secretion by first (1stPH_est) and second phase (2ndPH_est) estimates.

Results: Sixty three subjects had impaired glucose tolerance (IGT), 132 impaired fasting glucose (IFG), 63 a mixed disorder (IFG/IGT). Insulin resistance was present only in IGT and IFG/IGT. IFG sub-jects had inappropriately low insulin secretionexclusively during fasting. In a stepwise logistic regression analysis BMI≥27, female sex and hy-pertension were associated to an altered 2h-PG during OGTT, while hypertension and age were linked to alterations in FPG. While overweight prevalence (BMI≥27) was higher in all glucose intolerance groups, obesity (BMI≥30) was typical of IGT. Overweight and obesity were related to higher insulin concentration, secretion and resistance. Obese normal glucose tolerant subjects were more insulin resistant than lean IFG patients.

Discussion: OGTT is essential to correctly establish the metabolic derangement of glucose intolerance. Obesity is significantly connected with the impairment of insulin metabolism even in subjects with normal FPG. Considering that both obesity and insulin resistance are independently associated to an increased cardiovascular risk, all overweight subjects, even with normal FPG, should be referred for OGTT evaluation to define glucose tolerance status in order to enforce adequate preventive actions.

glucose intolerance - IGT - IFG - obesity - BMI - insulin

References

• 1 Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.  Diabet Med. 1998;  15 539-553
• 2 American Diabetes Association . Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2005;  28 S37-S42
• 3 Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels.  Mol Genet Metab. 1998;  63 134-141
• 4 Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance.  Diabetes Care. 2003;  26 1333-1337
• 5 Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and beta-cell function.  Diabetes. 2004;  53 S34-S38
• 6 Conget I, Fernandez Real JM, Costa A, Casamitjana R, Ricart W. Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus.  Med Clin. 2001;  116 491-492
• 7 Crepaldi G, Belfiore F, Bosello O, Caviezel F, Contaldo F, Enzi G, Melchionda N. Italian Consensus Conference; overweight, obesity and health (ICC S.O.S 1991).  Recenti Prog Med. 1991;  82 417-434
• 8 DECODE Study Group. European Diabetes Epidemiology Group . Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?.  Diabetes Care. 2003;  26 688-696
• 9 DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.  Metabolism. 1989;  38 387-395
• 10 Diamantopoulos EJ, Andreadis EA, Tsourous GI, Ifanti GK, Katsanou PM, Georgiopoulos DX, Vassilopoulos CV, Dimitriadis G, Raptis SA. Metabolic syndrome and prediabetes identify overlapping but not identical populations.  Exp Clin Endocrinol Diabetes. 2006;  114 377-383
• 11 Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).  J Clin Invest. 1997;  100 1166-1173
• 12 Ferrannini E, Camastra S, Gastaldelli A, Maria Sironi A, Natali A, Muscelli E, Mingrone G, Mari A. Beta-cell function in obesity: effects of weight loss.  Diabetes. 2004;  53 S26-S33
• 13 Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A, Mari A, DeFronzo RA. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance.  Diabetologia. 2003;  46 1211-1219
• 14 Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.  J Clin Endocrinol Metab. 2005;  90 493-500
• 15 Festa A, D’Agostino Jr R, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.  Diabetes. 2004;  53 1549-1555
• 16 Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus.  Diabetes Care. 2003;  26 3160-3167
• 17 Guerrero-Romero F, Rodriguez-Moran M. Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose.  J Diabetes Complications. 2001;  15 34-37
• 18 Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.  Diabetes Res Clin Pract. 2000;  47 177-184
• 19 Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The mexico city diabetes study.  Diabetes Care. 1996;  19 1138-1141
• 20 Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?.  JAMA. 1990;  263 2893-2898
• 21 Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD study. Risk factors in impaired glucose tolerance for atherosclerosis and diabetes.  Diabet Med. 2000;  17 835-840
• 22 Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis.  Diabet Med. 1999;  16 212-218
• 23 Letizia C, Iacobellis G, Caliumi C, Leonetti F, Cotesta D, Ribaudo MC, Petramala L, Cianci R, Celi M, D'Erasmo E, Mario U Di. Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity.  Exp Clin Endocrinol Diabetes. 2005;  113 171-175
• 24 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 25 Mittendorfer B. Insulin resistance: sex matters.  Curr Opin Clin Nutr Metab Care. 2005;  8 367-372
• 26 National Diabetes Data Group . Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.  Diabetes. 1979;  28 1039-1057
• 27 Novoa FJ, Boronat M, Saavedra P, Diaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.  Diabetes Care. 2005;  28 2388-2393
• 28 O’Rahilly S, Hattersley A, Vaag A, Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?.  Lancet. 1994;  344 585-589
• 29 Piche ME, Despres JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?.  Diabet Med. 2004;  21 730-737
• 30 Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.  JAMA. 1995;  273 1855-1861
• 31 Staiger H, Haring HU. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis.  Exp Clin Endocrinol Diabetes. 2005;  113 67-79
• 32 Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Haeften T Van, Renn W, Gerich J. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.  Diabetes Care. 2000;  23 295-301
• 33 Stumvoll M, Haeften T Van, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times.  Diabetes Care. 2001;  24 796-797
• 34 Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.  Diabetes Care. 2004;  27 1728-1734
• 35 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the expert committee on the diagnosis and classification of diabetes mellitus.  Diabetes Care. 1997;  20 1183-1197
• 36 Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.  Diabetes. 2000;  49 975-980
• 37 Tuomilehto J. Point: a glucose tolerance test is important for clinical practice.  Diabetes Care. 2002;  25 1880-1882
• 38 Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.  Diabetes. 1999;  48 2197-2203

Correspondence